INS and metabolic dysfunction-associated steatotic liver disease: Metabolic syndrome markers were worse in NAFLD, with elevated fasting insulin, triglycerides, and low-density lipoprotein (LDL), and lower high-density lipoprotein (HDL) (all p < 0.05).